| Authors: |
Dörr J; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Gregor L; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Lacher SB; Institute of Molecular Immunology, TUM University Hospital, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.; Servier Deutschland, Munich, Germany., Oner A; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Sun Y; Mass General Cancer Center, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Piseddu I; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Medicine II, LMU University Hospital, Munich, Germany.; Gene Center, Department of Biochemistry, LMU Munich, Munich, Germany., Fertig L; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Spajic S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Lesch S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Michaelides S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Seifert M; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Gottschlich A; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Medicine III, LMU University Hospital, LMU, Munich, Germany., Samson N; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Majed L; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Briukhovetska D; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Simnica D; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Hartmann V; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Gabriel K; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Cohen S; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Boland GM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Andreu-Sanz D; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Carlini E; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Stock S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Medicine III, LMU University Hospital, LMU, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany., Holtermann A; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany., Müller PJ; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Strzalkowski T; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Trefny MP; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Endres S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München-German Research Center for Environmental Health Neuherberg, Munich, Germany., Jenkins RW; Mass General Cancer Center, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Böttcher JP; Institute of Molecular Immunology, TUM University Hospital, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.; M3 Research Center, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.; Department of Experimental Immunology, Institute of Immunology, University of Tübingen, Tübingen, Germany., Kobold S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München-German Research Center for Environmental Health Neuherberg, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; German Center for Lung Research (DZL), Partner Site Munich, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de. |
